Wouter Coppieters

senior scientist

University of Liege
Country flagBelgium
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (2)

The endangered mountain gorilla, Gorilla beringei beringei, faces numerous threats to its survival, highlighting the urgent need for genomic resources to aid conservation efforts. Here, we present a near telomere-to-telomere, haplotype-phased reference genome assembly for a male mountain gorilla generated using PacBio HiFi (26.77× ave. coverage) and Oxford Nanopore Technologies (52.87× ave. coverage) data. The resulting non-scaffolded assembly exhibits exceptional contiguity, with contig N50 of ∼95 Mbp for the combined pseudohaplotype (3,540,458,497 bp), 56.5 Mbp (3.1 Gbp) and 51.0 Mbp (3.2 Gbp) for each haplotype, an average QV of 65.15 (error rate = 3.1 × 10-7), and a BUSCO score of 98.4%. These represent substantial improvements over most other available primate genomes. This first high-quality reference genome of the mountain gorilla provides an invaluable resource for future studies on gorilla evolution, adaptation, and conservation, ultimately contributing to the long-term survival of this iconic species.

Year:

2024

Genes whose expression is affected in a consistent manner by GWAS-identified risk variants and the disease process, constitute preferred drug targets. We herein combine integrated cis-eQTL analysis in 27 blood cell populations and 43 intestinal cell types of the ileum, colon and rectum, and information on gene expression in patients, to search for putative drug targets for inflammatory bowel disease (IBD). We detect >95K cis-eQTL that affect >13K e-genes and cluster in >24K regulatory modules (RM). We uncover matching RM for 140 risk loci, implicating >300 e-genes not previously connected to IBD, and find 152 IBD-matching e-genes whose expression is perturbed in the blood or gut of patients. We identify entrectinib, a small molecule inhibiting the NRLP3 inflammasome by binding NEK7, as a promising repurposing candidate for IBD.

Year:

2024

Collaborators (10)

Alice Mayer

University of Oxford

UNITED KINGDOM
View details

Kourosh Salehi-Ashtiani

Associate Professor

NYU Abu Dhabi

UNITED ARAB EMIRATES
View details

Jean-Claude TWIZERE

Associate Professor

University of Liege

BELGIUM
View details

Evan Eichler

Howard Hughes Medical Institute

UNITED STATES
View details

David Nelson

Senior Research Scientist

NYU Abu Dhabi

UNITED ARAB EMIRATES
View details

Michel Georges

University of Liege

BELGIUM
View details

Edouard Louis

University of Liege

BELGIUM
View details

Yumie Tokunaga-Mizoro

University of Liege

BELGIUM
View details

Emmanouil Dermitzakis

Professor

University of Geneva, Faculty of Medicine

SWITZERLAND
View details

Yasutaka Mizoro

The University of Manchester

UNITED KINGDOM
View details